|
CDK2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.206400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.533590E-01 |
| Normal-vs-Stage2 |
1.009630E-01 |
| Normal-vs-Stage3 |
4.468000E-01 |
| Normal-vs-Stage4 |
4.395800E-01 |
| Stage1-vs-Stage2 |
8.137400E-03 |
| Stage1-vs-Stage3 |
6.054200E-01 |
| Stage1-vs-Stage4 |
7.513800E-01 |
| Stage2-vs-Stage3 |
3.241600E-02 |
| Stage2-vs-Stage4 |
2.973700E-02 |
| Stage3-vs-Stage4 |
9.383400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.227610E-01 |
| Normal-vs-AfricanAmerican |
2.009400E-01 |
| Normal-vs-Asian |
7.683800E-02 |
| Caucasian-vs-AfricanAmerican |
5.328800E-01 |
| Caucasian-vs-Asian |
4.480200E-01 |
| AfricanAmerican-vs-Asian |
9.579400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.014200E-01 |
| Normal-vs-Female |
2.762600E-01 |
| Male-vs-Female |
6.031400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.025900E-02 |
| Normal-vs-Age(41-60Yrs) |
5.759800E-01 |
| Normal-vs-Age(61-80Yrs) |
6.251000E-01 |
| Normal-vs-Age(81-100Yrs) |
9.993200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.476300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.484500E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.470200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.408600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.423800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.228200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.139000E-01 |
| Classical-VS-Follicular |
5.97149996117707E-10 |
| Classical-VS-Other |
3.431200E-01 |
| Classical-VS-Normal |
2.982100E-02 |
| Tall-VS-Follicular |
4.024800E-04 |
| Tall-VS-Other |
2.989600E-01 |
| Tall-VS-Normal |
5.876100E-02 |
| Follicular-VS-Other |
3.167400E-01 |
| Follicular-VS-Normal |
7.440000E-03 |
| Other-VS-Normal |
9.427600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.228400E-01 |
| Normal-vs-N1 |
4.097200E-01 |
| N0-vs-N1 |
1.826830E-01 |
|
|
